Oxana Beskrovnaya

Oxana is an accomplished R&D leader with a strong track record of discovering and developing first-in-class therapeutics for rare genetic diseases. Prior to joining Dyne, Oxana served as head of musculoskeletal and renal research in Sanofi’s rare disease and neurological unit, advancing a pipeline of drug candidates using multiple therapeutic modalities, including nucleic acids, proteins, and small molecules. Previously, she served in various capacities of increasing responsibility at Genzyme, managing research in genetics, disease mechanisms, target discovery/validation, and translational biomarkers in rare renal, metabolic, skeletal, and neuromuscular diseases. She has authored numerous patents, invited reviews, editorials, book chapters, and original research articles in major scientific journals, including Nature, Nature Medicine, Cell, and Molecular Cell. Oxana received her Ph.D. in genetics from Moscow Genetics Institute, followed by postdoctoral fellowship training in neuromuscular diseases at the Howard Hughes Medical Institute at the University of Iowa.